Agilent Technologies is a global leader in life sciences, diagnostics and applied chemical markets providing trusted answers to customers’ most challenging questions.
In 2015, Agilent made the decision to take a step in a new direction with the formation of our Cell Analysis Division with the acquisition of Seahorse Bioscience followed by Luxcel Biosciences in 2017, Acea Biosciences in 2018, and most recently BioTek Instruments.
Agilent’s expanding Cell Analysis portfolio provides solutions and support spanning many research areas. Agilent offers cell analysis solutions that detect discrete changes in cellular bioenergetics in real-time. Real-time cell measurements provide a clear window into the critical functions driving differentiation, cell signaling, proliferation, activation, toxicity and biosynthesis. Move beyond analyzing what your cells are to reveal a clearer picture of what they do.
CANCER METABOLISM PAGE:
1. Discover Agilent Seahorse XF applications in cancer metabolism
Visit our cancer metabolism webpage” :
2 “View our collection of cancer eSeminars available to view on-demand”
eSeminar page anchored to cancer: